205 related articles for article (PubMed ID: 9225681)
1. Cytokine profile of myelin basic protein-reactive T cells in multiple sclerosis and healthy individuals.
Hermans G; Stinissen P; Hauben L; Van den Berg-Loonen E; Raus J; Zhang J
Ann Neurol; 1997 Jul; 42(1):18-27. PubMed ID: 9225681
[TBL] [Abstract][Full Text] [Related]
2. Myelin basic protein-specific T lymphocyte repertoire in multiple sclerosis. Complexity of the response and dominance of nested epitopes due to recruitment of multiple T cell clones.
Meinl E; Weber F; Drexler K; Morelle C; Ott M; Saruhan-Direskeneli G; Goebels N; Ertl B; Jechart G; Giegerich G
J Clin Invest; 1993 Dec; 92(6):2633-43. PubMed ID: 7504690
[TBL] [Abstract][Full Text] [Related]
3. Clonal expansion of myelin basic protein-reactive T cells in patients with multiple sclerosis: restricted T cell receptor V gene rearrangements and CDR3 sequence.
Vandevyver C; Mertens N; van den Elsen P; Medaer R; Raus J; Zhang J
Eur J Immunol; 1995 Apr; 25(4):958-68. PubMed ID: 7537675
[TBL] [Abstract][Full Text] [Related]
4. Cytokine secretion profile of myelin basic protein-specific T cells in multiple sclerosis.
Rohowsky-Kochan C; Molinaro D; Cook SD
Mult Scler; 2000 Apr; 6(2):69-77. PubMed ID: 10773850
[TBL] [Abstract][Full Text] [Related]
5. Genetic control of multiple sclerosis: increased production of lymphotoxin and tumor necrosis factor-alpha by HLA-DR2+ T cells.
Zipp F; Weber F; Huber S; Sotgiu S; Czlonkowska A; Holler E; Albert E; Weiss EH; Wekerle H; Hohlfeld R
Ann Neurol; 1995 Nov; 38(5):723-30. PubMed ID: 7486863
[TBL] [Abstract][Full Text] [Related]
6. The T-cell response to myelin basic protein in familial multiple sclerosis: diversity of fine specificity, restricting elements, and T-cell receptor usage.
Joshi N; Usuku K; Hauser SL
Ann Neurol; 1993 Sep; 34(3):385-93. PubMed ID: 7689820
[TBL] [Abstract][Full Text] [Related]
7. The phosphodiesterase i.v. inhibitor rolipram in vitro reduces the numbers of MBP-reactive IFN-gamma and TNF-alpha mRNA expressing blood mononuclear cells in patients with multiple sclerosis.
Navikas V; Matusevicius D; Söderström M; Pirskanen R; Fredrikson S; Link H
Clin Neuropharmacol; 1998; 21(4):236-44. PubMed ID: 9704165
[TBL] [Abstract][Full Text] [Related]
8. The effect of beta-interferon therapy on myelin basic protein-elicited CD4+ T cell proliferation and cytokine production in multiple sclerosis.
Hedegaard CJ; Krakauer M; Bendtzen K; Sørensen PS; Sellebjerg F; Nielsen CH
Clin Immunol; 2008 Oct; 129(1):80-9. PubMed ID: 18653385
[TBL] [Abstract][Full Text] [Related]
9. Myelin basic protein-specific T-cell responses in identical twins discordant or concordant for multiple sclerosis.
Martin R; Voskuhl R; Flerlage M; McFarlin DE; McFarland HF
Ann Neurol; 1993 Oct; 34(4):524-35. PubMed ID: 7692808
[TBL] [Abstract][Full Text] [Related]
10. Cellular and humoral immune responses against autoreactive T cells in multiple sclerosis patients after T cell vaccination.
Hermans G; Denzer U; Lohse A; Raus J; Stinissen P
J Autoimmun; 1999 Sep; 13(2):233-46. PubMed ID: 10479392
[TBL] [Abstract][Full Text] [Related]
11. Tumour necrosis factor-alpha synthesis by cerebrospinal-fluid-derived T cell clones from patients with multiple sclerosis.
Benvenuto R; Paroli M; Buttinelli C; Franco A; Barnaba V; Fieschi C; Balsano F
Clin Exp Immunol; 1991 Apr; 84(1):97-102. PubMed ID: 2015713
[TBL] [Abstract][Full Text] [Related]
12. Quantitative gene expression of cytokines in peripheral blood leukocytes stimulated in vitro: modulation by the anti-tumor nerosis factor-alpha antibody infliximab and comparison with the mucosal cytokine expression in patients with ulcerative colitis.
Moriconi F; Raddatz D; Ho NA; Yeruva S; Dudas J; Ramadori G
Transl Res; 2007 Oct; 150(4):223-32. PubMed ID: 17900510
[TBL] [Abstract][Full Text] [Related]
13. HLA restriction and TCR usage of T lymphocytes specific for a novel candidate autoantigen, X2 MBP, in multiple sclerosis.
Voskuhl RR; Robinson ED; Segal BM; Tranquill L; Camphausen K; Albert PS; Richert JR; McFarland HF
J Immunol; 1994 Nov; 153(10):4834-44. PubMed ID: 7525716
[TBL] [Abstract][Full Text] [Related]
14. Tumour necrosis factor-alpha synthesis by cerebrospinal-fluid-derived T cell clones from patients with multiple sclerosis.
Buttinelli C; Toma L; Falcone MM; Salvetti M; Ristori G; Barnaba V; Fieschi C
Ital J Neurol Sci; 1992 Dec; 13(9 Suppl 14):79-83. PubMed ID: 1345744
[TBL] [Abstract][Full Text] [Related]
15. [T-cell interferon-gamma, tumor necrosis factor-alpha and interleukin-6 receptor binding in patients with multiple sclerosis. Effects of interferon-beta-1b treatment].
Bongioanni P; Romano MR; Boccardi B; Lombardo F; Moscato G; Mosti S; Baldini C; Nuti S; Meucci G; Rossi B
Rev Neurol; 1999 Nov 16-30; 29(10):893-9. PubMed ID: 10637835
[TBL] [Abstract][Full Text] [Related]
16. Defective production of anti-inflammatory cytokine, TGF-beta by T cell lines of patients with active multiple sclerosis.
Mokhtarian F; Shi Y; Shirazian D; Morgante L; Miller A; Grob D
J Immunol; 1994 Jun; 152(12):6003-10. PubMed ID: 8207225
[TBL] [Abstract][Full Text] [Related]
17. Isolation of myelin basic protein-specific T cells predominantly from the memory T-cell compartment in multiple sclerosis.
Burns J; Bartholomew B; Lobo S
Ann Neurol; 1999 Jan; 45(1):33-9. PubMed ID: 9894874
[TBL] [Abstract][Full Text] [Related]
18. Blood CD8+ T cell responses against myelin determinants in multiple sclerosis and healthy individuals.
Berthelot L; Laplaud DA; Pettré S; Ballet C; Michel L; Hillion S; Braudeau C; Connan F; Lefrère F; Wiertlewski S; Guillet JG; Brouard S; Choppin J; Soulillou JP
Eur J Immunol; 2008 Jul; 38(7):1889-99. PubMed ID: 18506883
[TBL] [Abstract][Full Text] [Related]
19. Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis.
Link J
Acta Neurol Scand Suppl; 1994; 158():1-58. PubMed ID: 7732782
[TBL] [Abstract][Full Text] [Related]
20. Cross-reactivity with myelin basic protein and human herpesvirus-6 in multiple sclerosis.
Tejada-Simon MV; Zang YC; Hong J; Rivera VM; Zhang JZ
Ann Neurol; 2003 Feb; 53(2):189-97. PubMed ID: 12557285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
